Saturday, September 5, 2026

Abaxx Exchange Hits Record Volume While Fending Off Viceroy Short Report

Abaxx Exchange logged its best-ever trading month in June 2026, days after short-seller Viceroy Research accused parent Abaxx Technologies of wrongdoing. Regulators in Singapore and Canada are now reviewing the dispute, a cross-border test case for how exchanges answer short-and-distort campaigns.

LM Salvado
LM Salvado

July 12, 2026

Source Trace Score2 source documents2 with a live linkVerifiability: Strong
Abaxx Exchange Hits Record Volume While Fending Off Viceroy Short Report
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

Abaxx Exchange posted record trading volume in June 2026, days after short-seller Viceroy Research accused parent Abaxx Technologies of wrongdoing.1 The spike gives Abaxx a data-driven rebuttal to the allegations.

The clash spans two financial hubs. Abaxx Technologies is dual-listed in Toronto and holds exchange operations tied to Singapore, so the fallout now runs through regulators on two continents.1 Viceroy's report used a short-and-distort strategy, publishing negative claims while holding a short position.2 Abaxx has rejected the findings as misinformation.1

Short-and-distort campaigns are a recurring feature of global markets, from Hindenburg Research's assaults on firms in the US and India to activist shorts targeting Chinese and European issuers. Abaxx's response follows a familiar international playbook: hire outside counsel and push the fight into regulatory channels.1

Abaxx retained law firm Paul Weiss to investigate the allegations.1 It also engaged two regulators directly: Singapore's Monetary Authority (MAS) and Canada's Investment Regulatory Organization (CIRO).1 The CIRO request goes further than a standard rebuttal, asking the regulator to examine Viceroy's own trading around the report's release.1 That puts the short-seller's tactics, not just its claims, under cross-border scrutiny.

For traders worldwide, June's volume record is the harder data point. A short-and-distort report aims to pressure a stock price by amplifying negative claims. Record activity on Abaxx Exchange in the same window suggests participants kept transacting rather than pulling back, even as headline risk around the parent company escalated.1

The dispute now runs on two tracks. Paul Weiss's investigation and the regulatory reviews at MAS and CIRO will determine whether Viceroy's allegations hold up.1 Meanwhile, Abaxx Exchange's trading desk has already delivered its own answer: record June volumes, an outcome that runs counter to what a short-and-distort campaign typically produces.1

Sentiment remains mixed but improving, reflecting a global market weighing unresolved regulatory questions in two jurisdictions against the exchange's demonstrated trading strength.12

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score2 source documents2 with a live linkVerifiability: Strong
  1. [1]Press releaseGlobeNewswire· June 22, 2026
    Abaxx Continues to Provide Facts Refuting Ongoing Misinformation and Reaffirms Strong Business Fundamentals
  2. [2]Press releaseGlobeNewswire· June 30, 2026
    Raytech Holding Limited Announces Closing of Approximately $6.2 Million Registered Direct Offering of its Ordinary Shares

In this story · Knowledge Files

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Network, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Funding Surge: Capital Floods Fintech, Foundation Models, and Autonomous Systems
A concentrated burst of AI-linked funding on 2026-08-28 pushed well over $1.5B into companies spanning fraud/identity fintech (Socure, which also acquired Fravity), foundation models (Stability AI), AI agents and enterprise tooling (Instinct, Generalist AI, Emerald AI, Owner), and AI-adjacent autonomous/aerospace ventures (Gatik, Regent Craft). The breadth and simultaneity of these rounds signal that investor appetite for AI is not concentrated in a single vertical but is broadening into applied and infrastructure-adjacent domains, with consolidation (Socure-Fravity) beginning alongside fresh capital formation.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,269 source documents archived
Query this data → isubstrate.com